Risk of Atrial Fibrillation and Stroke in Patients with Hypertrophic Obstructive Cardiomyopathy Treated by Modified Morrow Septal Myectomy: Reports of a Propensity Score Matching Cohort

Yi-Xi Zou, Xilin Zhang, Jianpeng Zheng, Feng Lü, Gregory Y.h. Lip, Ying Bai, Yu-Feng Sun, Weihua GuoJournal of Cardiovascular Development and Disease 2025 · DOI

TL;DR

This study investigates the impact of modified Morrow septal myectomy (MMSM) on atrial fibrillation (AF) and stroke risk in patients with obstructive hypertrophic cardiomyopathy (OHCM). The findings suggest that MMSM significantly reduces stroke risk, while AF risk initially decreases but then sharply increases after six years post-surgery.

What Problem Does This Paper Address?

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition characterized by thickened heart muscle. Obstructive HCM (OHCM) specifically involves a blockage in the left ventricular outflow tract (LVOTO), leading to symptoms like shortness of breath and chest pain. While medication and other interventions exist, surgical septal myectomy, particularly the modified Morrow septal myectomy (MMSM), is a primary treatment for relieving LVOTO. However, the long-term effects of MMSM on the risk of atrial fibrillation (AF) and stroke, two significant complications of OHCM, have not been fully elucidated. This paper aims to fill that knowledge gap by examining these risks in a large cohort of OHCM patients.

Methods

The researchers conducted a retrospective cohort study using data from the Beijing Municipal Health Commission Information Center (BMHCIC) database, spanning from January 2014 to December 2020. They identified 6426 patients with OHCM. To account for potential confounding factors and selection bias, they employed propensity score matching to create two comparable groups: 1890 patients who underwent MMSM (Group 1) and 1890 patients who did not receive any surgery (Group 2).

Key diagnostic criteria for OHCM, AF, and stroke were based on International Classification of Diseases (ICD-10-CM) codes and confirmed through medical records. Echocardiographic parameters were analyzed to assess the impact of the surgery. The primary outcomes, new-onset AF and stroke after discharge, were evaluated using Cox regression analysis and Kaplan-Meier survival curves. Statistical significance was set at p < 0.05.

Datasets

The study utilized the Beijing Municipal Health Commission Information Center (BMHCIC) database, a comprehensive government health surveillance system that collects medical information from 153 hospitals in the Beijing area. This retrospective dataset included in-hospital and outpatient records for OHCM patients.

Key Insights and Ideas

  • Stroke Reduction is Clear: The most striking finding is the significant reduction in stroke risk for patients who underwent MMSM compared to those who did not. This suggests that the surgical intervention directly addresses factors contributing to stroke in OHCM.
  • AF Risk is Nuanced: The relationship between MMSM and AF risk is more complex. While there's an initial decrease in AF risk within the first six years post-surgery, there's a concerning sharp increase in AF risk beyond this six-year mark. This suggests that MMSM might not be a permanent solution for AF prevention in the long term.
  • MMSM's Mechanism for Stroke Prevention: The authors hypothesize that MMSM's success in reducing stroke risk is due to its ability to relieve LVOTO, improve cerebral perfusion, and stabilize hemodynamics. Additionally, by reducing blood stasis in the atria and ventricles, it may decrease thrombus formation, regardless of AF status.

Key Results

  • After propensity score matching, the study included 1890 patients in each group.
  • Stroke: MMSM was associated with a significantly decreased risk of stroke (adjusted Hazard Ratio [aHR]: 0.4, 95% Confidence Interval [CI]: 0.2–0.6, p < 0.001). This was confirmed by Kaplan-Meier analysis (p < 0.001).
  • Atrial Fibrillation (AF): There was no statistically significant difference in the overall risk of new-onset AF between the MMSM group and the no-surgery group (aHR: 1.0, 95% CI: 0.7–1.5, p = 0.991). However, Kaplan-Meier analysis revealed that the risk of AF was lower in the MMSM group in the first 6 years, but sharply increased thereafter.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Nature: As a multi-center retrospective study, it's subject to inherent biases in data collection and reporting.
  • ICD Code Reliance: Diagnoses and procedures relied on ICD codes, which can have limitations. However, they mitigated this by reviewing detailed echocardiographic data.
  • Concomitant Procedures: Patients without MMSM might have undergone other procedures (e.g., alcohol ablation), making direct comparison challenging.
  • Missing Data: Echocardiographic parameters were sometimes missing for the non-surgery group, preventing their inclusion in baseline characteristic analysis for propensity score matching.
  • Anti-arrhythmic Drug Use: Data on anti-arrhythmic drug distribution was not available, which could have influenced AF outcomes.

Future work should focus on:

  • Long-term AF Monitoring: Further investigation into the reasons for the sharp increase in AF risk beyond six years post-MMSM is crucial.
  • Concomitant Procedures: Exploring the role and necessity of procedures like atrial appendage ligation (AAL) in patients undergoing MMSM, especially those at high risk of postoperative AF.
  • Prospective Studies: The authors recommend future large prospective clinical studies to further validate these findings and explore the long-term implications of MMSM.

Summary updated

Abstract

MMSM is associated with a decreased risk of stroke in OHCM patients. The risk of AF decreased in the first 6 years since receiving MMSM and then sharply increased beyond 6 years after MMSM.
BibTeX
@article{zou2025risk,
  author = {Yi-Xi Zou and Xilin Zhang and Jianpeng Zheng and Feng Lü and Gregory Y.H. Lip and Ying Bai and Yu-Feng Sun and Weihua Guo},
  title = {{Risk of Atrial Fibrillation and Stroke in Patients with Hypertrophic Obstructive Cardiomyopathy Treated by Modified Morrow Septal Myectomy: Reports of a Propensity Score Matching Cohort}},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2025},
  doi = {10.3390/jcdd12090321},
}
Figure